Guyer Charles Greg — SEC Form 4 filings
SEC reporting owner CIK 1811096. 12 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-29 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 28,798 shares, $1,848,422 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 16,486 shares @ $60.46 ($996,744) in BIOMARIN PHARMACEUTICAL INC, filed 2026-03-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | 12 | — | 3 legs · 28,798 sh · $1,848,422 | 23 |
Form 4 filings — Guyer Charles Greg
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 1,693 @ $56.05 | EDGAR |
| 2026-03-17 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 9,109 @ $58.51 · Grant/award (A): 14,990 @ $0 · Grant/award (A): 35,680 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 16,486 @ $60.46 | EDGAR |
| 2026-02-26 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 6,176 @ $0 · Grant/award (A): 6,675 @ $0 · Grant/award (A): 2,371 @ $0 | EDGAR |
| 2025-03-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 20,127 @ $69.44 · Grant/award (A): 13,310 @ $0 · Grant/award (A): 30,880 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 7,034 @ $71.28 | EDGAR |
| 2025-03-04 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 4,287 @ $71.16 | EDGAR |
| 2025-02-27 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 11,040 @ $0 · Grant/award (A): 9,660 @ $0 · Grant/award (A): 9,367 @ $0 | EDGAR |
| 2024-11-14 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 55 @ $56.01 · Sale (S): 5,278 @ $66.37 | EDGAR |
| 2024-05-07 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 245 @ $68.65 · Tax withholding (F): 4,440 @ $82.44 | EDGAR |
| 2024-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 10,550 @ $0 · Tax withholding (F): 20,424 @ $83.87 · Grant/award (A): 23,630 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 20,840 @ $0 · Grant/award (A): 9,063 @ $0 · Grant/award (A): 6,284 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1811096 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →